Jade Biosciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Jade Biosciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$113.54M	-$74.60M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$127.41M	-$69.63M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-3.00	$-2.44
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-3.00	$-2.44

Balance Sheet

	2025-12-31	2024-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$88.40M	$33.75M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$349.78M	$80.33M
Everything the company owes — debt, unpaid bills, and other obligations.	$17.26M	$3.90M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$332.52M	$76.43M

Cash Flow Statement

	2025-12-31	2024-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$94.70M	-$71.20M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$196000	–
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$94.90M	–